key: cord-0857014-nkjv1dzb
authors: Pina, Alessandra; Farina, Andrea; Savonitto, Stefano
title: Immuno-mediated Sequential Dissection of Visceral Arteries: dramatic improvement after steroid therapy
date: 2022-02-23
journal: Am J Med
DOI: 10.1016/j.amjmed.2022.01.047
sha: 85e11b2bab695267ffd9b3b2d5dc3b6ff084a056
doc_id: 857014
cord_uid: nkjv1dzb

nan

We present the case of a young man with spontaneous, progressive, multivessel dissection of the abdominal arteries occurring a few days after SARS-CoV-2 vaccination. After a few days of conventional treatment, initiation of steroids and immunoglobulins produced a dramatic improvement of the clinical course, suggesting an immune-mediated causative mechanism.

A 50-year-old man presented with intense abdominal pain and vomiting since two days earlier. The patient was a smoker and suffered from hypertension but had no clinical history. He had completed the SARS-CoV-2 vaccination cycle a few days before with BNT162b2 (Pfizer-BioNTech). The abdominal CT scan showed focal dissection of the celiac trunk with intramural hematoma reaching the splenic, hepatic, and gastric arteries, without signs of intestinal ischemia (Fig1). In analogy with the treatment of type B aortic dissection, antihypertensive therapy was started in the ICCU, maintaining a systolic blood pressure target milder than usual to prevent intestinal ischemia. We started antiplatelet therapy with aspirin 100 mg and achieved pain control using paracetamol and morphine.

After four days, the patient experienced sudden rebound of abdominal pain and fever that were associated with the appearance at CT scan of bilateral thrombosis of the renal arteries with renal ischemia, due to probable dissection (Fig2). We started anticoagulant therapy using unfractionated heparin. Inflammatory markers were increased, while procalcitonin and blood cultures resulted negative. We excluded systemic vasculitis and collagen disease with rheumatologic evaluation, total-body FDG-PET CT-scan, and auto-antibodies test. A control CT scan four days later demonstrated further dissection of the Superior Mesenteric Artery.

in analogy with the recently described approach for SARS-CoV 2 Vaccine-Induced Thrombotic Thrombocytopenia (VITT) and vaccine-related myocarditis [1] [2] . We witnessed an immediate improvement of the clinical status and a fast decline in the values of all inflammatory markers, with no evidence of further disease progression. The patient remained monitorized with optimized antihypertensive therapy, warfarin, and aspirin. Opioids were rapidly de-escalated, and parenteral nutrition was stopped, while doses of corticosteroids were being reduced.

The patient was discharged twenty days later, with a tapering program of steroid therapy. At two months, a control CT-scan showed normalization of the renal and superior mesenteric arteries, with residual isolated dissection of the celiac trunk. The patient remained asymptomatic with well controlled blood pressure.

Spontaneous dissection of visceral arteries without aortic involvement is rare. A similar clinical presentation is described in Segmental Arterial Mediolysis (SMA), but in the absence of inflammation [3] . The natural history of this pathology remains unclear and guidelines for its management are not defined [4] . The clinical presentation can vary from mild symptoms to sharp abdominal pain, vomiting, abdominal distension, or diarrhea. The clinical course is unpredictable, as it can stabilize with progressive thrombosis of the false lumen or present progression of the dissection, obliteration of the true lumen and visceral ischemia, or rupture through the adventitia. In the absence of organ ischemia or impending arterial wall rupture conservative treatment is the preferred strategy, using antithrombotics, analgesics, and anti-hypertensives. We decided to start immunomodulatory therapy considering the recent vaccine exposure, and the rapid clinical and laboratory response to immunoglobulins and steroids strongly suggested an immune-mediated pathogenesis.

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia

Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTechCOVID-19 Vaccination

Natural history and management outcomes of segmental arterial mediolysis